Algo version: 0.98b
Takeda Pharmaceutical is listed at the NYSE Exchange
Takeda Pharmaceutical [TAK]
NYSE Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is Takeda Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Takeda Pharmaceutical pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Monday 30th of September 2024 were paid $0.33297 per share. Over the last 4 times between 2022 and 2024, Takeda Pharmaceutical has paid $1.16473 with an average of $0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Takeda Pharmaceutical 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $20.38, you would have made a loss of $-7.09 per share or -34.79%

Yes, the average daily trading liquidity for Takeda Pharmaceutical is $1.70 million. You should therefore be able to get in and out of your positions relatively fast.

Takeda Pharmaceutical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.17, the company's ability to pay off the debt is normal. Takeda Pharmaceutical has a good net profit margin of 6.38% and should have high tolerances against inflation.

We have calculated the inflation risk for Takeda Pharmaceutical to be low [0.4 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.